cell biology2 Flashcards
hypoxia inducible factor 1 (HIF1A)
The alpha subunits of HIF are hydroxylated at conserved proline residues by HIF prolyl-hydroxylases, allowing their recognition and ubiquitination by the VHL E3 ubiquitin ligase, which labels them for rapid degradation by the proteasome. This occurs only in normoxic conditions. In hypoxic conditions, HIF prolyl-hydroxylase is inhibited, since it utilizes oxygen as a cosubstrate. HIF-1, when stabilized by hypoxic conditions, upregulates several genes to promote survival in low-oxygen conditions. These include glycolysis enzymes, which allow ATP synthesis in an oxygen-independent manner, and vascular endothelial growth factor (VEGF), which promotes angiogenesis. HIF is necessary for tumor growth because most cancers demand high metabolic activity and are only supplied by structurally or functionally inadequate vasculature. Activation of HIF allows for enhanced angiogenesis, which in turn allows for increased glucose intake. While HIF is mostly active in hypoxic conditions, VHL-defective renal carcinoma cells show constitutive activation of HIF even in oxygenated environments.
Von Hippel–Lindau tumor suppressor
The VHL protein (pVHL) is involved in the regulation of a protein known as hypoxia inducible factor 1α (HIF1α). This is a subunit of a heterodimeric transcription factor that at normal cellular oxygen levels is highly regulated. In normal physiological conditions, pVHL recognises and binds to HIF1α only when oxygen is present due to the post translational hydroxylation of 2 proline residues within the HIF1α protein. pVHL is an E3 ligase that ubiquitinates HIF1α and causes its degradation by the proteasome. In low oxygen conditions or in cases of VHL disease where the VHL gene is mutated, pVHL does not bind to HIF1α. This allows the subunit to dimerise with HIF1β and activate the transcription of a number of genes, including vascular endothelial growth factor, platelet-derived growth factor B, erythropoietin and genes involved in glucose uptake and metabolism.
WHY REGULATE MEMBRANE FUSION?
All cellular membranes are composed from a lipid bilayer with charged residues facing the outside and interacting with water molecules. As a consequence, the membrane fusion thermodynamically is highly inefficient event, since it needs to overcome the repulsive ionic forces and dissipate the hydration between to lipid bilayers. Thus, cell need to have the machinery that increases the efficiency of membrane fusion. In addition, cell needs to ensure the specificity of membrane fusion to ensure that the vesicular cargo is delivered to the correct destination.
REGULATION OF INTRACELLULAR MEMBRANE FUSION
A transport vesicle fusion involves many coordinated steps. First it needs to be delivered to the fusion site via help of molecular motor proteins that move along actin or microtubule tracks. Once delivered to the appropriate destination it needs to fuse with the target membrane. That is achieved by a help of a set of cellular proteins known as SNAREs (soluble NSF attachment protein receptor).
SNARE classes and functions
The primary role of SNARE proteins is to mediate vesicle fusion, that is, the exocytosis of cellular transport vesicles with the cell membrane at the porosome or with a target compartment (such as a lysosome). There are three main classes of SNAREs: syntaxins, VAMPs (vesicle associated membrane protein) and SNAPs (synaptosome associated protein). VAMP is located in transport vesicle, while syntaxin and SNAP are located in target membrane. SNAREs are small, abundant and mostly plasma membrane-bound proteins. Although they vary considerably in structure and size, all share a segment in their cytosolic domain called a SNARE motif that consists of 60-70 amino acids that are capable of reversible assembly into tight, four-helix bundles called “trans”-SNARE complexes. The ‘zipper’ model of SNARE function postulates that the SNARE core complex ‘zips’ from the membrane-dis- tal amino termini to the membrane-proximal carboxyl termini, and the formation of the stable SNARE com- plex overcomes the energy barrier to drive fusion of the lipid bilayers. Many neurotoxins directly affect SNARE complexes. Such toxins as the botulinum and tetanus toxins work by targeting the SNARE components. These toxins prevent proper vesicle recycling and result in poor muscle control, spasms, paralysis, and even death. There are multiple types of each kind of SNARE proteins which leads to its specificity of fusion
syntaxins
has transmembrane domain and three helix domain and sits on the targeted plasma membrane. It can form coiled coil complex with its self using the three helix domains. N-sec1 creates a functional structure but keeps it in inactive conformation until it recieves a signal. In this way it regulates when vesicles can fuse when n-sec1 is signaled to leave leading to fusion of membranse
VAMPs (vesicle associated membrane protein)
Sits on synaptic vesicles. Has one transmembrane domain and huge helix domain
SNAPs (synaptosome associated protein)
has two helix domains and transmembrane domain in between. Also sits of targeted plasma membrane.
NSF and αSNAP protein function
Once the fusion occurred, cell needs to recycle the SNARE proteins for another fusion events. Since SNARE complexes are highly stable, cell ahs a set of proteins, namely NSF (N-ethyl-maleimide sensitive fusion protein) and αSNAP (soluble NSF attachment protein) to disassemble SNARE complex. The NSF uses ATP hydrolysis to generate energy needed to disassemble the SNARE complex by unraveling the coiled-coil interactions of the SNARE complex domain
Sec1 protein function.
After disassembly of SNARE complex, the SNARE proteins need to be refolded to the active conformation. That is achieved by the Sec1 protein, which binds and changes syntaxin into active conformation.
VIRAL MEDIATED MEMBRANE FUSION
The class of so-called enveloped viruses (includes HIV, ebola, influenza viruses) also needs to go through membrane fusion in order to infect cells. Viruses have developed fusion machinery that is remarkably similar to SNARE fusion. This machinery also achieves both objectives of fusion, ensures that it is efficient and specific. The examples discussed in the class are influenza and HIV viruses, although the mechanisms of other enveloped virus fusion are very similar. Viral fusion is achieved by help of specialized viral fusion proteins. This protein contains transmembrane domain at the one end (it is inserted into viral membrane) and highly hydrophobic fusion domain. Normally, fusion domain is folded and hidden within viral protein. Upon receiving specific signal (in case of influenza virus it is change in pH), the fusion domain is exposed and inserted into target cell membrane. That is immediately followed by refolding of fusion protein leading to the fusion of viral and cellular membranes.
Why are cells rich in potassium but poor in sodium?
One idea concerns how the oceans grew salty as cells evolved (about a billion years ago). The early oceans were relatively rich in potassium; they have grown more salty with sodium over time. The reason is that, while there are about equal parts potassium and sodium in the earth’s crust, silicates (soils) bind potassium more tightly than they bind sodium. Thus, as the rains fell, they preferentially leached sodium out of the soil, loading up the oceans with sodium. Evidently, it was easier for cells to evolve mechanisms allowing them to retain their primitive potassium-rich intracellular milieu than to evolve enzymes more tolerant of sodium.
Intracellular Fluid
Intracellular fluids are high in potassium, magnesium, and polar macromolecules and low in sodium and chloride ions. There are about 27l total in the body.
Extracellular fluid
In humans, the normal glucose concentration of extracellular fluid that is regulated by homeostasis is approximately 5 mM/L, and the pH is tightly regulated by buffers around 7.4. The volume of ECF is typically 15 L, of which 12 L is interstitial fluid and 3 L is plasma. Interstitial fluid makes up 16% of human body weight, and blood plasma, 4%. It is high in Na and Cl and low in potassium and polar macromolecules.
The Structure of the Plasma Membrane
Membranes are mostly lipid molecules, which are impermeable to water and charged substance. Proteins provide pathways for water and solutes to get across. Lipids are also ‘strong’, in an electric sense. That is, they can keep opposite electric charges separated, without collapsing. As we will see, the cytoplasm of nearly all cells is electrically negative, compared to the ECF, because cells contain a few more negative than positive ions. The excess anions create an electrical potential difference between the inside and the outside of the cell, and this membrane potential, which governs some vital cell processes, is wholly dependent on the integrity of the plasma membrane. The ability of the membrane to withstand the imposed electric force (which has a whopping strength of about 100,000 volts/cm=50mV/5nm(thickness of plasma membrane)) is due to its lipid composition. therefore a small change (a few mV) in the electric force can have a large effect on transmembrane proteins. The second physiologically important point about membranes is that they are apparently shot full of holes. That is, many charged and polar molecules can cross membranes, no thanks to the lipids. Their ability to do so depends primarily on the presence of certain proteins inserted in the lipid membrane; these proteins have special abilities to transport particular substances between the ECF and the ICF. From a functional (i.e., our) standpoint, there are two kinds of proteins that mediate the transmembrane movements of charged substances: channels and transporters
Channels
most are selective for particular ions. For example, sodium channels will pass Na+ ions, but not K+, or Cl-, or other ions. Some channels permit just about any cation to pass, but not anions; these are called ‘non-selective cation channels’. Second, some channels contain molecular gates. Substances can pass through the channel only when the gate is open. opening and closing of the gates can govern important functions, like action potentials. The gates of channels are controlled by a variety of forces. Some depend on the electric field (membrane potential) across the membrane. The gates in many such voltage-gated channels swing open when the membrane is depolarized (the cell is made less negative inside). Gates in other channels require mechanical stimulation (stretching of the membrane) to open (e.g., hair cells in the cochlea; touch receptors in the skin). Still others require the binding of a particular chemical (synaptic receptors for a neurotransmitter). Others open or close depending on temperature (cutaneous thermal receptors). Some gates in channels depend on more than one force, making for some pretty complicated behavior. For example, a channel gate may require the binding of a particular chemical substance and, simultaneously, a particular value of membrane potential in order to open up. Some channels contain no gates (e.g., water channels, also called aquaporins) , while others contain two gates, and both have to be open to allow ions to pass.
patch clamp technique
The Patch Clamp was invented in 1980. A micropipette is lowered onto a cell, but instead of punching through the membrane, it sucks onto it, and a tight seal is formed between the membrane and glass pipette. In this situation, it is possible to see the tiny electric currents produced by the openings and closings of single ion channels. Examples are shown on the right (with the averaged response at the bottom). It is astonishing to see a single protein molecule at work, in real time, in its native membrane environment. The work won a Nobel Prize in 1991 for its German inventors, Bert Sakmann and Erwin Neher. allows one to see individual ion channels at work. A glass pipette touches a cell, and gentle suction draws a membrane bleb into the mouth of the pipette, forming a tight seal with the glass. Then, when a channel gate opens, it is possible to record the electric current through the channel. As channels flicker open and closed, one can describe their behavior in great quantitative detail.
Ion channel structure
Channels differ with respect to the ion they let pass (for example, Na+, K+, Cl−), the ways in which they may be regulated, the number of subunits of which they are composed and other aspects of structure. Channels belonging to the largest class, which includes the voltage-gated channels that underlie the nerve impulse, consists of four subunits with six transmembrane helices each. On activation, these helices move about and open the pore. Two of these six helices are separated by a loop that lines the pore and is the primary determinant of ion selectivity and conductance in this channel class and some others.
Transporters
Some substances cross membranes by binding to proteins and being escorted (‘carried’) across. Such a mechanism is needed to transport big molecules, like glucose, selectively. Transporters are also needed in order to pump molecules across a membrane, that is, to concentrate them on one side against their energy gradient. Such pumping is called active transport, to distinguish it from passive transport pathways, like channels. Pumping means performing work, and the energy to do the work can come from different sources. If the energy comes directly from metabolism (usually splitting ATP), the transport is called primary active transport. An example is the Na+ pump, which extrudes Na+ from cells, and requires ATP. If the energy comes from other sources, it is called secondary active transport. There are many examples of secondary active transport, and most of them use the energy released when Na+ ions leak into cells, and the energy released is captured and used to pump another ion across the membrane. Ultimately, secondary active transport also depends on metabolism. We are only just beginning to acquire information about the molecular structure of transporters, and that information suggests that they are very similar to channels. For example, by mutating only a few amino acid residues, a transporter of chloride and hydrogen ions, which pumps only about a hundred ions per second, can be turned into a chloride-selective ion channel that allows the passage of tens of thousands of ions per second.
Von Hippel–Lindau syndrome
autosomal dominant inherited cancer sysndrome. 1:36,000 live births, mutation in the VHL tumor suppressor gene. Characterized by formation of cystic and highly vascularized tumors in many organs:Cerebellar, spinal cord, and retinal hemangioblastomas, Endolymphatic sac (inner ear) tumors, Bilateral kidney cysts and renal cell carcinomas,Pancreatic cysts and islet cell tumors, Pheochromocytomas, Cystadenomas of the genitourinary tract. Tumors called hemangioblastomas are characteristic of von Hippel-Lindau syndrome. These growths are made of newly formed blood vessels. Although they are typically noncancerous, they can cause serious or life-threatening complications. Hemangioblastomas that develop in the brain and spinal cord can cause headaches, vomiting, weakness, and a loss of muscle coordination (ataxia). Hemangioblastomas can also occur in the light-sensitive tissue that lines the back of the eye (the retina). These tumors, which are also called retinal angiomas, may cause vision loss.Von Hippel-Lindau syndrome is associated with a type of tumor called a pheochromocytoma, which most commonly occurs in the adrenal glands (small hormone-producing glands located on top of each kidney). Pheochromocytomas are usually noncancerous. They may cause no symptoms, but in some cases they are associated with headaches, panic attacks, excess sweating, or dangerously high blood pressure that may not respond to medication. Pheochromocytomas are particularly dangerous if they develop during pregnancy.
recommended screening and follow up for VHL patients
Age 5-15: Annual physical examination and neurological assessment by pediatrician, Annual examination by ophthalmologist, Annual test for fractionated metanephrines, Annual abdominal ultrasonography after age 8, Complete audiology assessment by an audiologist every 2-3 years; annually if any hearing loss, tinnitus, or vertigo, MRI with contrast of the internal auditory canal to check for ELST if recurrent ear infections.Age 16 and beyond: Annual eye/ retinal examination by ophthalmologist, Annual physical examination by physician, Annual test for fractionated metanephrines, Annual quality ultrasound, and at least every other year MRI scan of abdomen, Annual abdominal MRI or MIBG scan if biochemical abnormalities found, MRI brain, C/T/L-spine, with thin cuts through the posterior fossa, to rule out hemangioblastomas and ELST; every 2-3 years, Audiology assessment by an audiologist every 2-3 years.
VHL type 1
VHL mutation resulting in total or partial VHL loss due to improper folding, this leads to up regulation of HIF. Clinical manifestation: Hemangioblastoma, Renal cell carcinoma, Low risk of pheochromocytoma
VHL type 2A
VHL missense mutation leading to upregulation of HIF, inability to stabilize microtubules. Clinical manifestation: Hemangioblastoma, Low risk of renal cell carcinoma, Low risk of pheochromocytoma
VHL type 2B
VHL missense mutation which resulats in up regulation of HIF. Clinical manifestations: hemangioblastoma, high risk of renal cell carcinoma, and high risk of pheochromocytoma
VHL type 2c
VHL missense mutation. pVHL maintins ability to downregulate HIF. Decreased binding to fibronectin, defective fibronectin matrix assemble. . Clinical manifestations: pheochromocytoma only
Clear cell papillary renal cell carcinoma
a rare subtype of renal cell carcinoma (RCC). VHL is most common cause of inherited ccRCC. Familial ccRCC (4%)- typically multifocal, bilateral, early age onset. Sporadic ccRCC (96%)- solitary, unilateral, later age of onset. Patients with familial VHL are at risk of developing of up to 600 tumors per kidney. Goal of surgical management for VHL-associated kidney tumors is to prevent metastasis while preserving renal function. Other genetic alterations in ccRCC are BAP1 and PRBM1which are also located on Chr 3p. Loss of 3p causes heterozygous loss of BAP1 and PRBM1 too. Subsequent PRBM1 or BAP1mutations results in ccRCC with different features and outcomes.
pheochromocytoma
Up to 25% of pheochromocytomas may be familial. Mutations of the genes VHL, RET, NF1 (Gene 17 Neurofibromatosis type 1), SDHB and SDHD are all known to cause familial pheochromocytoma, therefore this disease may be accompanied by Von Hippel–Lindau disease, neurofibromatosis,[3] or familial paraganglioma depending on the mutation. Pheochromocytoma is a tumor of the multiple endocrine neoplasia syndrome
hemangioblastoma
Hemangioblastomas are composed of endothelial cells, pericytes and stromal cells. In VHL syndrome the von Hippel-Lindau protein (pVHL) is dysfunctional, usually due to mutation and/or gene silencing. In normal circumstances, pVHL is involved in the inhibition of hypoxia-inducible factor 1 α (HIF-1α) by ubiquitin mediated proteosomal degradation. In these dysfunctional cells pVHL cannot degrade HIF-1α, causing it to accumulate. HIF-1α causes the production of vascular endothelial growth factor, platelet derived growth factor B, erythropoietin and transforming growth factor alpha, which act to stimulate growth of cells within the tumour. Tumors of the central nervous system that originate from the vascular system usually during middle-age.
fibronectin
a high-molecular weight (~440kDa) glycoprotein of the extracellular matrix that binds to membrane-spanning receptor proteins called integrins. Similar to integrins, fibronectin binds extracellular matrix components such as collagen, fibrin, and heparan sulfate proteoglycans (e.g. syndecans). Fibronectin has numerous functions that ensure the normal functioning of vertebrate organisms. It is involved in cell adhesion, growth, migration, and differentiation. Cellular fibronectin is assembled into the extracellular matrix, an insoluble network that separates and supports the organs and tissues of an organism.
Processes regulated by HIF
Angiogenesis, Erythropoiesis, Anaerobic glycolysis, Glucose uptake, Extracellular matrix turnover, pH control, Apoptosis, Mitogenesis. Accumulaton of HIF-α results in over-expression of VEGF, TGF, PDGF
VEGF
a signal protein produced by cells that stimulates vasculogenesis and angiogenesis. It is part of the system that restores the oxygen supply to tissues when blood circulation is inadequate.
TGFbeta
exists in three known subtypes in humans, TGFβ1, TGFβ2, and TGFβ3. These are upregulated in Marfan’s syndrome and some human cancers, and play crucial roles in tissue regeneration, cell differentiation, embryonic development, and regulation of the immune system. Isoforms of transforming growth factor-beta (TGF-β1) are also thought to be involved in the pathogenesis of pre-eclampsia. TGFβ receptors are single pass serine/threonine kinase receptors.
PDGF
one of the numerous growth factors, or proteins that regulate cell growth and division. In particular, it plays a significant role in blood vessel formation (angiogenesis), the growth of blood vessels from already-existing blood vessel tissue. Uncontrolled angiogenesis is a characteristic of cancer.
Treatment options in metastatic renal cell carcinoma
immunotherapy, vascular endothelial growth factor inhibitors, mTOR inhibitors
mTOR inhibitiors
It regulates cellular metabolism, growth, and proliferation, and therefore is a target for the development of a number of mTOR inhibitors. There is also some cross talk with the VHL pathway. examples include temsirolimus and everolimus, non-infectious pneumonitis with mTOR inhibition (14%) Rule out infectious etiology. Options for treatment: Treatment interruption, Dose reduction, Treatment discontinuation, Corticosteroids.
vascular endothelial growth factor inhibitors
examples include sorafenib, sunitinib, bevacizumab, pazopanib, axitinb. Hypertension is a side effect
examples of immunotherapy
HD-IL2, IFN
high dose interleukin-2
nterleukin-2 (IL-2) is a cytokine produced endogenously by activated T cells and is commercially available as aldesleukin (Proleukin), a human recombinant product. IL-2 is effective in the treatment of a variety of malignancies, including renal cell carcinoma and melanoma, because it has both immune-modulating and antitumor properties. Although high-dose interleukin-2 (IL-2, Proleukin), a highly toxic agent used in the treatment of renal cell carcinoma and melanoma, was initially associated with treatment-related mortality, it can, in the appropriate setting, be administered safely. High-dose IL-2 is associated with significant morbidity; however, the incidence and severity of toxicities have decreased as clinicians have gained experience with this agent and implemented toxicity prevention and management strategies.
BAP1
a deubiquitinating enzyme that in humans is encoded by the BAP1 gene. BAP1 functions as the catalytic subunit of the Polycomb repressive deubiquitinase (PR-DUB) complex, which controls homeobox genes by regulating the amount of ubiquitinated Histone H2A in Nucleosomes bound to their promoters. In flies and humans, the PR-DUB complex is formed through the interaction of BAP1 and ASXL1 (Asx in fruit flies) BAP1 has also been shown to associate with other factors involved in chromatin modulation and transcriptional regulation, such as Host cell factor C1, which acts as an adaptor to couple E2F transcription factors to chromatin-modifying complexes during cell cycle progression. BAP1 somatic mutations were identified in a small number of breast and lung cancer cell lines, but BAP1 was first shown to act as a tumor suppressor in cultured cells, where its deubiquitinase (UCH) domain and Nuclear localization sequences were required for BAP1 to suppress cell growth
thermodynamic challenge for membrane fusion
you need to strip the water molecules from inbetween the charged polar heads and overcome the repulsive properties. This does not happen spontaneously. Machinary is required
structure of alpha helix on SNARE proteins
they have hydrophobic region on one side and hydrophilic on the other this allows them to form coiled- coil domain
Coiled coils
a structural motif in proteins in which 2-7 alpha-helices are coiled together like the strands of a rope (dimers and trimers are the most common types). Coiled coils usually contain a repeated pattern, hxxhcxc, of hydrophobic (h) and charged (c) amino-acid residues, referred to as a heptad repeat. The positions in the heptad repeat are usually labeled abcdefg, where a and d are the hydrophobic positions, often being occupied by isoleucine, leucine, or valine. Folding a sequence with this repeating pattern into an alpha-helical secondary structure causes the hydrophobic residues to be presented as a ‘stripe’ that coils gently around the helix in left-handed fashion, forming an amphipathic structure. The most favorable way for two such helices to arrange themselves in the water-filled environment of the cytoplasm is to wrap the hydrophobic strands against each other sandwiched between the hydrophilic amino acids. Thus, it is the burial of hydrophobic surfaces that provides the thermodynamic driving force for the oligomerization. The packing in a coiled-coil interface is exceptionally tight, with almost complete van der Waals contact between the side-chains of the a and d residues.
N-ethylmaleimide Sensitive Factor (NSF)
It is a homolog of helicase, is a ATPase, it unwinds the SNARE complex. It functions as a hexamor. It binds to the end of the SNARE and hydrolizes 6 ATPs to twist and unwind SNARE. AlphaSNARE is an adapter.
n-sec1
after the NSF does its work, SNARE is denatured. Nsec1 comes in and helps SNAREs to reform their correct conformation.